Intel vs. Impinj: Which Technology Stock Is a Better Buy in 2026?

Intel reported FY 2025 revenue of $52.9 billion, down 0.5%, but cut its net loss sharply to $267 million from a much larger loss in FY 2024; first-quarter sales later rose 7% year over year to $13.6 billion as its AI and foundry strategy gained traction. Impinj posted FY 2025 revenue of $361.1 million, down 1.4%, with a $10.8 million net loss and heavy customer concentration, though Q2 guidance calls for at least $103 million in sales. The article is a relative-value comparison favoring Intel, while highlighting execution, litigation, supply-chain, and customer-concentration risks for both names.

Analysis

The market is implicitly treating both names as “AI adjacency” beneficiaries, but the dispersion in quality is likely to widen over the next 2-4 quarters. Intel’s real option is not its legacy CPU base; it is whether foundry can convert strategic relevance into externally financed capex and utilization, which would materially improve operating leverage if customer wins cluster. That means the stock can stay structurally bid on narrative alone, but the earnings bridge remains fragile until external wafer demand becomes visible in backlog or prepaid capacity commitments.

Impinj looks cleaner on operating momentum, but its concentration profile makes it more of a single-threaded supply-chain derivative than a broad IoT compounder. The hidden risk is that any one large customer slowing inventory restocking or renegotiating pricing can overwhelm otherwise healthy unit trends, especially with high SBC masking true cash conversion. In a risk-off tape, the market will likely punish PI more for concentration than it rewards the niche moat, even if top-line guidance improves sequentially.

The biggest second-order effect is on the rest of the semi ecosystem: if Intel’s foundry narrative gains credibility, it pressures capital allocation discipline at competing logic players and could create a valuation overhang for names trading on “manufacturing optionality” without clear utilization paths. Conversely, PI’s competitiveness depends on a stable outsourced manufacturing chain; any trade-policy or export-control friction that hits TSM-linked supply would show up first as lead-time volatility and then as customer hesitation, not just margin pressure. The contrarian view is that both stocks may be too expensive relative to execution risk: Intel is being paid for a turnaround that is still mostly forward-looking, while Impinj is being priced as a scarcity asset despite customer concentration and supplier dependence.

Key Decisions for Investors

• Prefer a 3-6 month long INTC / short NXPI pair: if foundry credibility improves, Intel’s multiple can re-rate while NXPI faces relative pressure from cycle-normalization and capital intensity; size it small because INTC’s execution risk remains high.
• For tactical upside, buy INTC call spreads 6-9 months out rather than outright stock; the setup benefits from narrative acceleration if AI/foundry headlines continue, but the spread caps premium burn if free cash flow stays negative.
• Fade PI strength on rallies with a 1-3 month horizon via covered calls or a partial short against a semiconductor basket; the risk/reward is skewed by customer concentration and outsized SBC, which can compress the multiple quickly if guidance underwhelms.
• If you want exposure to the AI capex complex without single-name execution risk, rotate capital away from both names into more diversified beneficiaries; the article’s setup suggests the best risk-adjusted trade is avoiding expensive “optionality” until utilization data confirms it.
• Set a trigger on INTC for evidence of external foundry bookings or customer prepayments; absent that within the next 1-2 quarters, treat any post-rally pullback as a chance to trim rather than add.